Indonesia | Indonesia’s New Regulatory Framework for Drug Promotion and Advertising

The Indonesian Food and Drug Authority (Badan Pengawas Obat dan Makanan – “BPOM”) has recently issued BPOM Regulation No. 7 of 2026 on Drug Promotion and Advertising (“BPOM Reg. 7/2026”), which revokes and replaces BPOM Regulation No. 2 of 2021 (“BPOM Reg. 2/2021”).

The issuance of BPOM Reg. 7/2026 introduces a new regulatory framework for drug promotion and advertising in Indonesia, including expanded provisions on drug promotion activities, revised procedures for obtaining advertising approvals, and the introduction of additional prohibitions relating to the promotion and advertising of pharmaceutical products.

To learn more, read our Advisory here.